Ocular Surface Epithelial Thickness Evaluation with Spectral-Domain Optical Coherence Tomography
Francoz et al.
IOVS 2011;52:9116-9123.
ABSTRACT
| FULL TEXT
Canaloplasty for primary open-angle glaucoma: long-term outcome
Grieshaber et al.
Br J Ophthalmol 2010;94:1478-1482.
ABSTRACT
| FULL TEXT
Effect of latanoprost and timolol on the histopathology of the human conjunctiva
Terai et al.
Br J Ophthalmol 2009;93:219-224.
ABSTRACT
| FULL TEXT
In Vitro Studies of Antiglaucomatous Prostaglandin Analogues: Travoprost with and without Benzalkonium Chloride and Preserved Latanoprost
Baudouin et al.
IOVS 2007;48:4123-4128.
ABSTRACT
| FULL TEXT
Measurement of inflammatory cytokines by multicytokine assay in tears of patients with glaucoma topically treated with chronic drugs
Malvitte et al.
Br J Ophthalmol 2007;91:29-32.
ABSTRACT
| FULL TEXT
Conjunctival markers as predictable markers for preoperative glaucoma assessment.
Pisella
Br J Ophthalmol 2006;90:1335-1336.
FULL TEXT
Trefoil factor family 1, MUC5AC and human leucocyte antigen-DR expression by conjunctival cells in patients with glaucoma treated with chronic drugs: could these markers predict the success of glaucoma surgery?
Souchier et al.
Br J Ophthalmol 2006;90:1366-1369.
ABSTRACT
| FULL TEXT
Effects of Antiglaucoma Drops on MMP and TIMP Balance in Conjunctival and Subconjunctival Tissue.
Ito et al.
IOVS 2006;47:823-830.
ABSTRACT
| FULL TEXT
In Vitro Study of Inflammatory Potential and Toxicity Profile of Latanoprost, Travoprost, and Bimatoprost in Conjunctiva-Derived Epithelial Cells
Guenoun et al.
IOVS 2005;46:2444-2450.
ABSTRACT
| FULL TEXT
Latanoprost Stimulates Secretion of Matrix Metalloproteinases in Tenon Fibroblasts Both In Vitro and In Vivo
Mietz et al.
IOVS 2003;44:5182-5188.
ABSTRACT
| FULL TEXT
Lyophilisates for drug delivery in ophthalmology: pharmacokinetics of fluorescein in the human anterior segment
Dinslage et al.
Br J Ophthalmol 2002;86:1114-1117.
ABSTRACT
| FULL TEXT
In vivo production of interferon {beta} by human Tenon's fibroblasts; a possible mediator for the development of chronic conjunctival inflammation
Chang et al.
Br J Ophthalmol 2002;86:611-615.
ABSTRACT
| FULL TEXT
Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication
Pisella et al.
Br J Ophthalmol 2002;86:418-423.
ABSTRACT
| FULL TEXT
Mitochondrial Activity and Glutathione Injury in Apoptosis Induced by Unpreserved and Preserved {beta}-Blockers on Chang Conjunctival Cells
Debbasch et al.
IOVS 2001;42:2525-2533.
ABSTRACT
| FULL TEXT
Human Tenon's Fibroblast-Produced IFN{beta} and the Prevention of T-Cell Apoptosis
Chang et al.
IOVS 2001;42:1531-1538.
ABSTRACT
| FULL TEXT
Quaternary Ammoniums and Other Preservatives' Contribution in Oxidative Stress and Apoptosis on Chang Conjunctival Cells
Debbasch et al.
IOVS 2001;42:642-652.
ABSTRACT
| FULL TEXT
Effect of Latanoprost and Timolol on the Histopathology of the Rabbit Conjunctiva
Mietz et al.
IOVS 2001;42:679-687.
ABSTRACT
| FULL TEXT
Short term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers
Baudouin and de Lunardo
Br J Ophthalmol 1998;82:39-42.
ABSTRACT
| FULL TEXT
Reversal of Topical Antiglaucoma Medication Effects on the Conjunctiva
Broadway et al.
Arch Ophthalmol 1996;114:262-267.
ABSTRACT
Adverse Effects of Topical Antiglaucoma Medication: II. The Outcome of Filtration Surgery
Broadway et al.
Arch Ophthalmol 1994;112:1446-1454.
ABSTRACT
